Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.485 USD | +5.04% | -0.22% | -9.98% |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 176M | |
+48.09% | 57.87B | |
+41.65% | 40.25B | |
-7.20% | 39.94B | |
-5.96% | 28.54B | |
+12.36% | 26.4B | |
-20.40% | 19.33B | |
+30.03% | 12.4B | |
-0.88% | 12.23B | |
+24.00% | 12.2B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- SVB Securities Adjusts Price Target on Abeona Therapeutics to $5 From $1, Maintains Market Perform Rating